174 related articles for article (PubMed ID: 10866349)
1. Future directions in the treatment of malignant gliomas with temozolomide.
Prados MD
Semin Oncol; 2000 Jun; 27(3 Suppl 6):41-6. PubMed ID: 10866349
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide in malignant gliomas.
Yung WK
Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide in malignant gliomas: current use and future targets.
Villano JL; Seery TE; Bressler LR
Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.
Koukourakis GV; Kouloulias V; Zacharias G; Papadimitriou C; Pantelakos P; Maravelis G; Fotineas A; Beli I; Chaldeopoulos D; Kouvaris J
Molecules; 2009 Apr; 14(4):1561-77. PubMed ID: 19384285
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.
Chamberlain MC
Expert Rev Neurother; 2010 Oct; 10(10):1537-44. PubMed ID: 20925470
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide and treatment of malignant glioma.
Friedman HS; Kerby T; Calvert H
Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
[TBL] [Abstract][Full Text] [Related]
7. Management of glioblastoma.
Aoki T; Hashimoto N; Matsutani M
Expert Opin Pharmacother; 2007 Dec; 8(18):3133-46. PubMed ID: 18035958
[TBL] [Abstract][Full Text] [Related]
8. Problems of Glioblastoma Multiforme Drug Resistance.
Stavrovskaya AA; Shushanov SS; Rybalkina EY
Biochemistry (Mosc); 2016 Feb; 81(2):91-100. PubMed ID: 27260389
[TBL] [Abstract][Full Text] [Related]
9. Pulsed versus conventional radiation therapy in combination with temozolomide in a murine orthotopic model of glioblastoma multiforme.
Lee DY; Chunta JL; Park SS; Huang J; Martinez AA; Grills IS; Krueger SA; Wilson GD; Marples B
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):978-85. PubMed ID: 23845846
[TBL] [Abstract][Full Text] [Related]
10. Current and Future Drug Treatments for Glioblastomas.
Ohba S; Hirose Y
Curr Med Chem; 2016; 23(38):4309-4316. PubMed ID: 27758718
[TBL] [Abstract][Full Text] [Related]
11. Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide.
Messaoudi K; Clavreul A; Lagarce F
Drug Discov Today; 2015 Jul; 20(7):899-905. PubMed ID: 25744176
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme.
Martikainen JA; Kivioja A; Hallinen T; Vihinen P
Pharmacoeconomics; 2005; 23(8):803-15. PubMed ID: 16097842
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells.
Wong ST; Zhang XQ; Zhuang JT; Chan HL; Li CH; Leung GK
Anticancer Res; 2012 Jul; 32(7):2835-41. PubMed ID: 22753745
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
Chou KN; Lin YC; Liu MY; Chang PY
J Clin Neurosci; 2014 Apr; 21(4):701-4. PubMed ID: 24291476
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide: a milestone in the pharmacotherapy of brain tumors.
Weller M; Steinbach JP; Wick W
Future Oncol; 2005 Dec; 1(6):747-54. PubMed ID: 16556052
[TBL] [Abstract][Full Text] [Related]
16. Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy.
Dinca EB; Sarkaria JN; Schroeder MA; Carlson BL; Voicu R; Gupta N; Berger MS; James CD
J Neurosurg; 2007 Sep; 107(3):610-6. PubMed ID: 17886562
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
Yung WK; Albright RE; Olson J; Fredericks R; Fink K; Prados MD; Brada M; Spence A; Hohl RJ; Shapiro W; Glantz M; Greenberg H; Selker RG; Vick NA; Rampling R; Friedman H; Phillips P; Bruner J; Yue N; Osoba D; Zaknoen S; Levin VA
Br J Cancer; 2000 Sep; 83(5):588-93. PubMed ID: 10944597
[TBL] [Abstract][Full Text] [Related]
18. Role of temozolomide in pediatric brain tumors.
Barone G; Maurizi P; Tamburrini G; Riccardi R
Childs Nerv Syst; 2006 Jul; 22(7):652-61. PubMed ID: 16565851
[TBL] [Abstract][Full Text] [Related]
19. Helping patients make the best decision regarding duration of temozolomide chemotherapy treatment.
Groves MD; Plummer AB
Continuum (Minneap Minn); 2012 Apr; 18(2):421-5. PubMed ID: 22810137
[TBL] [Abstract][Full Text] [Related]
20. Current and future developments in the use of temozolomide for the treatment of brain tumours.
Stupp R; Gander M; Leyvraz S; Newlands E
Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]